Quiz: Sulphonamides: History, Chemistry, and Clinical Use — 12 Fragen

1. What is the primary role or purpose of sulphonamides in antimicrobial therapy?

A. To directly kill bacteria through lysis

B. To enhance human immune response against infections

C. To serve as a vaccine component against bacterial infections

D. To inhibit bacterial growth by interfering with bacterial synthesis pathways

Answer: (D)

Erklärung

Sulphonamides are primarily used to inhibit bacterial growth by interfering with bacterial synthesis pathways, specifically by blocking folic acid synthesis. This bacteriostatic mechanism prevents bacteria from multiplying, giving the immune system a better chance to eliminate the infection.

2. How should knowledge of sulphonamide pharmacokinetics influence clinical practice in administering these drugs?

A. Use higher doses to overcome rapid absorption from the GIT

B. Prescribe without concern for urinary pH since solubility is unaffected

C. Adjust dosing in patients with renal impairment to prevent accumulation

D. Avoid use in all patients with liver disease due to metabolism issues

Answer: (C)

Erklärung

Understanding that sulphonamides are rapidly absorbed and undergo acetylation in the liver, with their metabolites less soluble in urine, helps clinicians adjust dosing in patients with renal impairment to prevent accumulation and crystalluria. Since metabolites are less soluble in acidic urine, monitoring urinary pH and kidney function is important to minimize side effects. The other options are incorrect because solubility is affected by urinary pH, not metabolism issues in all liver diseases, and higher doses are not necessary due to rapid absorption but need to be tailored to renal function.

3. When were sulphonamides first established as effective antimicrobial agents against bacterial infections?

A. During the 1930s

B. In the 1950s

C. In the early 1900s

D. In the 1970s

Answer: (A)

Erklärung

The source describes sulphonamides as having a significant place in medical history as the first effective antimicrobial agents against bacterial infections, with early research involving the dye Prontosil red tested by Domagk. This historical context aligns with their discovery and establishment in the 1930s, making this the correct period. The other options are later periods that do not match the initial discovery and use described in the source.

4. What does the combination of cotrimoxazole (sulfamethoxazole and trimethoprim) primarily do in antibacterial therapy?

A. It enhances human immune response, indirectly killing bacteria.

B. It blocks bacterial cell wall synthesis, making it effective against all bacterial types.

C. It inhibits bacterial folate synthesis at two different steps, leading to a synergistic bactericidal effect and an expanded spectrum of activity.

D. It solely inhibits bacterial DNA replication, with no effect on folate pathways.

Answer: (C)

Erklärung

The combination of cotrimoxazole inhibits bacterial folate synthesis by targeting two different enzymes—dihydropteroate synthase with sulfamethoxazole and dihydrofolate reductase with trimethoprim—leading to a synergistic bactericidal effect and broadening the spectrum of activity.

5. What specific enzyme do sulphonamides inhibit to exert their antibacterial action?

A. Dihydropteroate synthase

B. DNA polymerase

C. RNA polymerase

D. Peptidoglycan synthase

Answer: (A)

Erklärung

Sulphonamides inhibit bacterial folate synthesis by competitively binding to dihydropteroate synthase, an enzyme essential for the synthesis of dihydrofolic acid from PABA. This inhibition prevents bacteria from producing folic acid, which is necessary for DNA synthesis, thereby exerting their antibacterial effect.

6. What is the classification of trimethoprim, a component of cotrimoxazole?

A. Cephalosporin

B. Diaminopyrimidine

C. Aminoglycoside

D. Macrolide

Answer: (B)

Erklärung

Trimethoprim is classified as a diaminopyrimidine, a class of drugs that selectively inhibit bacterial dihydrofolate reductase, crucial for bacterial folate synthesis. It is part of the cotrimoxazole combination, which acts synergistically to inhibit bacterial growth.

7. Who is credited with early research on sulphonamides' antibacterial activity and their effectiveness against pyogenic bacteria?

A. Robert Koch

B. Gerhard Domagk

C. Louis Pasteur

D. Alexander Fleming

Answer: (B)

Erklärung

Gerhard Domagk included Prontosil red in early research and observed its high efficacy against streptococcal infections, making him credited with the discovery of sulphonamides' antibacterial properties.

8. What does the classification 'sulphonamide' refer to?

A. A specific dye used in early research

B. A group of antibiotics derived from penicillin

C. A class of antimicrobial agents that inhibit bacterial growth

D. A type of bacterial enzyme involved in folate synthesis

Answer: (C)

Erklärung

Sulphonamides are classified as a class of antimicrobial agents known for their ability to inhibit bacterial growth by interfering with bacterial synthesis pathways, specifically folic acid synthesis.

9. What is the primary role or purpose of sulphonamides in antimicrobial therapy?

A. To reduce inflammation in tissues

B. To modulate the immune response

C. To kill fungi directly

D. To inhibit bacterial folate synthesis

Answer: (D)

Erklärung

Sulphonamides primarily act as antibacterial agents by inhibiting bacterial folate synthesis, which is essential for bacterial growth. They do not have direct antifungal, anti-inflammatory, or immune-modulating purposes, making the inhibition of bacterial folate synthesis their main function.

10. When was cotrimoxazole, the fixed dose combination of sulfamethoxazole and trimethoprim, established as a clinical antimicrobial therapy?

A. 1980s

B. 1960s

C. 1950s

D. 1970s

Answer: (B)

Erklärung

Cotrimoxazole was established as a widely used antimicrobial in the 1960s, when the combination of sulfamethoxazole and trimethoprim was introduced to enhance antibacterial efficacy through synergistic action.

11. How do sulfadiazine and sulfamethoxazole differ in their pharmacokinetic absorption properties?

A. Sulfadiazine is not absorbed from the GIT, unlike sulfamethoxazole.

B. Sulfadiazine is absorbed more rapidly than sulfamethoxazole.

C. Sulfadiazine is absorbed more slowly than sulfamethoxazole.

D. Both are absorbed at the same rate.

Answer: (B)

Erklärung

Sulfadiazine is recognized for its rapid absorption, whereas sulfamethoxazole has a slower absorption rate, as explicitly stated in the source. This difference influences their clinical applications, such as sulfadiazine's use in meningitis due to its quick CSF penetration.

12. Which of the following bacterial resistance mechanisms directly causes a decrease in the effectiveness of sulphonamide drugs?

A. Development of bacterial cell wall thickening

B. Production of beta-lactamase enzymes

C. Increase in bacterial PABA production

D. Mutation in bacterial ribosomal RNA

Answer: (C)

Erklärung

Increased PABA production by bacteria outcompetes sulphonamides for the enzyme dihydropteroate synthase, directly reducing the drug's effectiveness. The other options are resistance mechanisms for different antibiotics or unrelated to sulphonamide action.